Anti-Mullerian Hormone-to-Testosterone Ratio is Predictive of Positive Sperm Retrieval in Men with Idiopathic Non-Obstructive Azoospermia

Massimo Alfano, Eugenio Ventimiglia, Irene Locatelli, Paolo Capogrosso, Walter Cazzaniga, Filippo Pederzoli, Nicola Frego, Rayan Matloob, Antonino Saccà, Luca Pagliardini, Paola Viganò, Pietro Zerbi, Manuela Nebuloni, Marina Pontillo, Francesco Montorsi, Andrea Salonia, Massimo Alfano, Eugenio Ventimiglia, Irene Locatelli, Paolo Capogrosso, Walter Cazzaniga, Filippo Pederzoli, Nicola Frego, Rayan Matloob, Antonino Saccà, Luca Pagliardini, Paola Viganò, Pietro Zerbi, Manuela Nebuloni, Marina Pontillo, Francesco Montorsi, Andrea Salonia

Abstract

The lack of clinically-reliable biomarkers makes impossible to predict sperm retrieval outcomes at testicular sperm extraction (TESE) in men with non-obstructive azoospermia (NOA), resulting in up to 50% of unnecessary surgical interventions. Clinical data, hormonal profile and histological classification of testis parenchyma from 47 white-Caucasian idiopathic NOA (iNOA) men submitted to microdissection TESE (microTESE) were analyzed. Logistic regression analyses tested potential clinical predictors of positive sperm retrieval. The predictive accuracy of all variables was evaluated using the receiver operating characteristic-derived area under the curve, and the clinical net benefit estimated by a decision-curve analysis (DCA). Overall, 23 (49%) and 24 (51%) patients were classified as positive and negative sperm retrievals at microTESE. While circulating hormones associated to a condition of primary hypogonadism did not predict sperm retrieval, levels of anti-Mullerian hormone (AMH) and the ratio AMH-to-total Testosterone (AMH/tT) achieved independent predictor status for sperm retrieval at microTESE, with a predictive accuracy of 93% and 95%. Using cutoff values of <4.62 ng/ml for AMH and <1.02 for AMH/tT, positive sperm retrieval was predicted in all individuals, with 19 men out of 47 potentially spared from surgery. DCA findings demonstrated clinical net benefit using AMH and AMH/tT for patient selection at microTESE.

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Figure 1
Figure 1
Serum levels of AMH and AMH/tT ratio values did not allow to stratifying histological classification of human spermatogenesis. (A,B) Descriptive classification of human spermatogenesis was performed using Johnsen’s (43) and McLachlan’s (42) score. Score for assessing spermatogenesis in testicular biopsy according to the Johnsen score: 10 = complete spermatogenesis and perfect tubules; 9 = many spermatozoa present but disorganized spermatogenesis; 8 = few spermatozoa present; 7 = no spermatozoa but many spermatids present; 6 = few spermatids present; 5 = nospermatozoa or spermatids present but many spermatocytes present; 4 = few spermatocytes present; 3 = only spermatogonia present; 2 = no germ cells present; 1 = neither germ cells nor Sertoli cells present. Score for assessing spermatogenesis in testicular biopsy according to the McLachlan score: 1 = normal testicular biopsy, full spermatogenesis in the entire biopsy and the presence of a normal inter-tubular tissue; 2 = hypospermatogenesis, when all stages of spermatogenesis are present but reduced to a varying degree, including varying patterns that can result in some tubules showing an epithelium containing Sertoli cells only; 3 = germ cell arrest, describes the total arrest at a particular stage, most often at the spermatogonial or primary spermatocyte stage; 4 = Sertoli cell only syndrome, when there are no tubules containing germ cells. Dot plots depict AMH levels and AMH/tT ratio values from the 23 positive sperm retrievals and 24 negative sperm retrievals; horizontal bars detail median values. Dashed lines represent the range of reference values for AMH levels. Lack of statistical significance among classes was evaluated by ANOVA. (C,D) Classification of testis parenchyma based on hyperplasia of Leydig cells. Dot plots show values from the 23 positive sperm retrievals and 24 negative sperm retrievals iNOA men; horizontal bars detail median values. Dashed lines represent the range of reference values for AMH levels. Lack of statistical significance between classes was evaluated by two-tail unpaired T test.
Figure 2
Figure 2
Circulating AMH levels and AMH/tT ratio values were predictive of sperm retrieval in iNOA men undergoing microTESE. (A,B) Dot plots depict values from the 23 positive sperm retrievals and 24 negative sperm retrievals iNOA men; horizontal bars detail median values. Dashed lines represent the range of reference values for the serum level of AMH. Statistical significance was evaluated by means of two-tail non-parametric T test (Mann-Whitney test). (C,D) ROC-derived curve, showing the AUC (Area Under the Curve) 95% CI (confidence intervals) and statistical significance. (E) Decision curve analysis showing the net benefit of AMH and AMH/tT on the prediction of positive sperm retrieval in iNOA men undergoing to microTESE. The use of the cutoff of <4.62 ng/ml for AMH and of <1.02 for AMH/tT resulted in positive net benefit; in the absence of any marker the 50% probability of sperm retrieval was associated to a net benefit of 0, whereas the use of the 2 markers at the threshold of 50% provided increased net benefit to 0.3–0.4, with the AMH/tT ratio scoring better than AMH.

References

    1. Jungwirth A. et al. Guidelines on male infertility. European Urology Association. (2015).
    1. Punab M, et al. Causes of male infertility: a 9-year prospective monocentre study on 1737 patients with reduced total sperm counts. Human reproduction. 2017;32:18–31.
    1. Olesen IA, et al. Clinical, genetic, biochemical, and testicular biopsy findings among 1,213 men evaluated for infertility. Fertility and sterility. 2017;107:74–82 e77. doi: 10.1016/j.fertnstert.2016.09.015.
    1. Stephen EH, Chandra A. Declining estimates of infertility in the United States: 1982-2002. Fertility and sterility. 2006;86:516–523. doi: 10.1016/j.fertnstert.2006.02.129.
    1. World Health Organization, Department of Reproductive Health and Research. WHO Laboratory Manual for the Examination and Processing of Human Semen. Fifth edition. (2010).
    1. O’Flynn O’Brien KL, Varghese AC, Agarwal A. The genetic causes of male factor infertility: a review. Fertility and sterility. 2010;93:1–12. doi: 10.1016/j.fertnstert.2009.10.045.
    1. Dohle GR, et al. Genetic risk factors in infertile men with severe oligozoospermia and azoospermia. Human reproduction. 2002;17:13–16. doi: 10.1093/humrep/17.1.13.
    1. Stahl PJ, et al. A decade of experience emphasizes that testing for Y microdeletions is essential in American men with azoospermia and severe oligozoospermia. Fertility and sterility. 2010;94:1753–1756. doi: 10.1016/j.fertnstert.2009.09.006.
    1. Eisenberg ML, Betts P, Herder D, Lamb DJ, Lipshultz LI. Increased risk of cancer among azoospermic men. Fertility and sterility. 2013;100:681–685. doi: 10.1016/j.fertnstert.2013.05.022.
    1. Oates R. Evaluation of the azoospermic male. Asian journal of andrology. 2012;14:82–87. doi: 10.1038/aja.2011.60.
    1. Lee JY, Dada R, Sabanegh E, Carpi A, Agarwal A. Role of genetics in azoospermia. Urology. 2011;77:598–601. doi: 10.1016/j.urology.2010.10.001.
    1. Bernie, A. M., Mata, D. A., Ramasamy, R. & Schlegel, P. N. Comparison of microdissection testicular sperm extraction, conventional testicular sperm extraction, and testicular sperm aspiration for nonobstructive azoospermia: a systematic review and meta-analysis. Fertility and sterility104, 1099–1103 e1091–1093, doi:10.1016/j.fertnstert.2015.07.1136 (2015).
    1. Reifsnyder JE, Ramasamy R, Husseini J, Schlegel PN. Role of optimizing testosterone before microdissection testicular sperm extraction in men with nonobstructive azoospermia. The Journal of Urology. 2012;188:532–536. doi: 10.1016/j.juro.2012.04.002.
    1. Condorelli R, Calogero AE, La Vignera S. Relationship between Testicular Volume and Conventional or Nonconventional Sperm Parameters. Int J Endocrinol. 2013;2013:145792. doi: 10.1155/2013/145792.
    1. Matuszczak E, Hermanowicz A, Komarowska M, Debek W. Serum AMH in Physiology and Pathology of Male Gonads. Int J Endocrinol. 2013;2013:128907. doi: 10.1155/2013/128907.
    1. Edelsztein NY, Grinspon RP, Schteingart HF, Rey RA. Anti-Mullerian hormone as a marker of steroid and gonadotropin action in the testis of children and adolescents with disorders of the gonadal axis. Int J Pediatr Endocrinol. 2016;2016:20. doi: 10.1186/s13633-016-0038-2.
    1. Teixeira J, Maheswaran S, Donahoe PK. Mullerian inhibiting substance: an instructive developmental hormone with diagnostic and possible therapeutic applications. Endocr Rev. 2001;22:657–674.
    1. World Health Organization, Human Reproduction Programme. (2017).
    1. Han TS, van Leer EM, Seidell JC, Lean ME. Waist circumference action levels in the identification of cardiovascular risk factors: prevalence study in a random sample. BMJ. 1995;311:1401–1405. doi: 10.1136/bmj.311.7017.1401.
    1. Schlegel PN. Testicular sperm extraction: microdissection improves sperm yield with minimal tissue excision. Human reproduction. 1999;14:131–135. doi: 10.1093/humrep/14.1.131.
    1. McLachlan RI, Rajpert-De Meyts E, Hoei-Hansen CE, de Kretser DM, Skakkebaek NE. Histological evaluation of the human testis–approaches to optimizing the clinical value of the assessment: mini review. Human reproduction. 2007;22:2–16. doi: 10.1093/humrep/del279.
    1. Johnsen SG. Testicular biopsy score count–a method for registration of spermatogenesis in human testes: normal values and results in 335 hypogonadal males. Hormones. 1970;1:2–25.
    1. Hajian-Tilaki K. Receiver Operating Characteristic (ROC) Curve Analysis for Medical Diagnostic Test Evaluation. Caspian J Intern Med. 2013;4:627–635.
    1. Vickers AJ, Van Calster B, Steyerberg EW. Net benefit approaches to the evaluation of prediction models, molecular markers, and diagnostic tests. BMJ. 2016;352:i6. doi: 10.1136/bmj.i6.
    1. Ramasamy R, et al. Age does not adversely affect sperm retrieval in men undergoing microdissection testicular sperm extraction. Fertility and sterility. 2014;101:653–655. doi: 10.1016/j.fertnstert.2013.11.123.
    1. Bryson CF, et al. Severe testicular atrophy does not affect the success of microdissection testicular sperm extraction. The Journal of Urology. 2014;191:175–178. doi: 10.1016/j.juro.2013.07.065.
    1. Arai T, Kitahara S, Horiuchi S, Sumi S, Yoshida K. Relationship of testicular volume to semen profiles and serum hormone concentrations in infertile Japanese males. International journal of fertility and women’s medicine. 1998;43:40–47.
    1. Ventimiglia E, et al. Validation of the American Society for Reproductive Medicine guidelines/recommendations in white European men presenting for couple’s infertility. Fertility and sterility. 2016;106:1076–1082 e1071. doi: 10.1016/j.fertnstert.2016.06.044.
    1. Tajar A, et al. Characteristics of secondary, primary, and compensated hypogonadism in aging men: evidence from the European Male Ageing Study. The Journal of clinical endocrinology and metabolism. 2010;95:1810–1818. doi: 10.1210/jc.2009-1796.
    1. Ventimiglia E, et al. Primary, secondary and compensated hypogonadism: a novel risk stratification for infertile men. Andrology. 2017;5:505–510. doi: 10.1111/andr.12335.
    1. Bernie AM, Ramasamy R, Schlegel PN. Predictive factors of successful microdissection testicular sperm extraction. Basic Clin Androl. 2013;23:5. doi: 10.1186/2051-4190-23-5.
    1. Tunc L, et al. Can serum Inhibin B and FSH levels, testicular histology and volume predict the outcome of testicular sperm extraction in patients with non-obstructive azoospermia? Int Urol Nephrol. 2006;38:629–635. doi: 10.1007/s11255-006-0095-1.
    1. Ishikawa T, Fujioka H, Fujisawa M. Clinical and hormonal findings in testicular maturation arrest. BJU international. 2004;94:1314–1316. doi: 10.1111/j.1464-410X.2004.05163.x.
    1. Smit M, Dohle GR, Wildhagen MF, Weber RF. Can inhibin-B predict the outcome of microsurgical epididymal sperm aspiration in patients with suspected primary obstructive azoospermia. Asian journal of andrology. 2007;9:382–387. doi: 10.1111/j.1745-7262.2007.00209.x.
    1. Aksglaede L, et al. Changes in anti-Mullerian hormone (AMH) throughout the life span: a population-based study of 1027 healthy males from birth (cord blood) to the age of 69 years. The Journal of clinical endocrinology and metabolism. 2010;95:5357–5364. doi: 10.1210/jc.2010-1207.
    1. Young J, et al. Testicular anti-mullerian hormone secretion is stimulated by recombinant human FSH in patients with congenital hypogonadotropic hypogonadism. The Journal of clinical endocrinology and metabolism. 2005;90:724–728. doi: 10.1210/jc.2004-0542.
    1. Chemes HE, et al. Physiological androgen insensitivity of the fetal, neonatal, and early infantile testis is explained by the ontogeny of the androgen receptor expression in Sertoli cells. The Journal of clinical endocrinology and metabolism. 2008;93:4408–4412. doi: 10.1210/jc.2008-0915.
    1. Cupisti S, et al. Correlations between anti-mullerian hormone, inhibin B, and activin A in follicular fluid in IVF/ICSI patients for assessing the maturation and developmental potential of oocytes. European journal of medical research. 2007;12:604–608.
    1. La Marca A, et al. Primary ovarian insufficiency due to steroidogenic cell autoimmunity is associated with a preserved pool of functioning follicles. The Journal of clinical endocrinology and metabolism. 2009;94:3816–3823. doi: 10.1210/jc.2009-0817.
    1. La Marca A, et al. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART) Hum Reprod Update. 2010;16:113–130. doi: 10.1093/humupd/dmp036.
    1. Muttukrishna S, et al. Serum anti-Mullerian hormone and inhibin B in disorders of spermatogenesis. Fertility and sterility. 2007;88:516–518. doi: 10.1016/j.fertnstert.2006.11.110.
    1. Tuttelmann F, et al. Anti-Mullerian hormone in men with normal and reduced sperm concentration and men with maldescended testes. Fertility and sterility. 2009;91:1812–1819. doi: 10.1016/j.fertnstert.2008.02.118.
    1. Isikoglu M, Ozgur K, Oehninger S, Ozdem S, Seleker M. Serum anti-Mullerian hormone levels do not predict the efficiency of testicular sperm retrieval in men with non-obstructive azoospermia. Gynecological endocrinology: the official journal of the International Society of Gynecological Endocrinology. 2006;22:256–260. doi: 10.1080/09513590600624366.
    1. Seifer DB, et al. Variations in serum mullerian inhibiting substance between white, black, and Hispanic women. Fertility and sterility. 2009;92:1674–1678. doi: 10.1016/j.fertnstert.2008.08.110.
    1. Plotton I, Garby L, Morel Y, Lejeune H. Decrease of anti-Mullerian hormone in genetic spermatogenic failure. Andrologia. 2012;44:349–354. doi: 10.1111/j.1439-0272.2010.01092.x.

Source: PubMed

3
Abonnere